Results with ENBREL in Moderate to Severe Rheumatoid Arthritis (RA)
ENBREL can reduce the pain, stiffness, and fatigue of rheumatoid
arthritis (RA). It can also help keep joint damage from getting worse. In medical studies, ENBREL has been shown to be clinically
effective in about 2 out of 3 adults with moderate to severe RA. Also, in
another medical study, 55% of patients who were evaluated 5 years after
beginning ENBREL therapy had no further progression of joint damage.
Clinical experience and proven results
ENBREL was the first medicine of its kind approved for moderate to severe rheumatoid arthritis.
ENBREL is the #1 most prescribed biologic by rheumatologists for RA.*
ENBREL can work quickly and continue working
Although many patients take ENBREL by itself, it can be taken with methotrexate. When ENBREL has been combined with methotrexate, some people have seen results in as little as 2 weeks. Most patients who show improvement do so within 3 months. Some patients saw even more improvement by 6 months of treatment with ENBREL and methotrexate.
Your results may vary. Because ENBREL works on the immune system, it can lower the ability of your immune system to fight infections and may raise other safety concerns.
Please see Full Prescribing Information, Important Safety Information, and Medication Guide for complete details about ENBREL.